CoChat

A Network Meta-Analysis Comparing Effects of Various Antidepressant Classes on the Digit Symbol Substitution Test (DSST) as a Measure of Cognitive Dysfunction in Patients with Major Depressive Disorder

Open access
Baune, Bernhard T, Brignone, Mélanie, Larsen, Klaus Groes · 2018 · International Journal of Neuropsychopharmacology

The DOI matches its Crossref record; 41 of the 42 references it cites were found in a registry or an index.

Abstract

Background: Major depressive disorder is a common condition that often includes cognitive dysfunction. A systematic literature review of studies and a network meta-analysis were carried out to assess the relative effect of antidepressants on cognitive dysfunction in major depressive disorder. Methods: MEDLINE, Embase, Cochrane, CDSR, and PsychINFO databases; clinical trial registries; and relevant conference abstracts were searched for randomized controlled trials assessing the effects of antidepressants/placebo on cognition. A network meta-analysis comparing antidepressants was conducted using a random effects model. Results: The database search retrieved 11337 citations, of which 72 randomized controlled trials from 103 publications met the inclusion criteria. The review identified 86 cognitive tests assessing the effect of antidepressants on cognitive functioning. However, the Digit Symbol Substitution Test, which targets multiple domains of cognition and is recognized as being sensitive to change, was the only test that was used across 12 of the included randomized controlled trials and that allowed the construction of a stable network suitable for the network meta-analysis. The interventions assessed included selective serotonin reuptake inhibitors, serotonin-norepinephrine reuptake inhibitors, and other non-selective serotonin reuptake inhibitors/serotonin-norepinephrine reuptake inhibitors. The network meta-analysis using the Digit Symbol Substitution Test showed that vortioxetine was the only antidepressant that improved cognitive dysfunction on the Digit Symbol Substitution Test vs placebo {standardized mean difference: 0.325 (95% CI = 0.120; 0.529, P=.009}. Compared with other antidepressants, vortioxetine was statistically more efficacious on the Digit Symbol Substitution Test vs escitalopram, nortriptyline, and the selective serotonin reuptake inhibitor and tricyclic antidepressant classes. Conclusions: This study highlighted the large variability in measures used to assess cognitive functioning. The findings on the Digit Symbol Substitution Test indicate differential effects of various antidepressants on improving cognitive function in patients with major depressive disorder.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1093/ijnp/pyx070

Cites

41 of 41 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1. Flow diagram for the identification and selection of studies. Note: 12 studies that assessed Digit Symbol Substitution Test (DSST) were included in the final network of evidence. Abbreviations: ADT, antidepressant therapy; MDD, major depressive disorder; RCT, randomized controlled trial.
Figure 1. Flow diagram for the identification and selection of studies. Note: 12 studies that assessed Digit Symbol Substitution Test (DSST) were included in the final network of evidence. Abbreviations: ADT, antidepressant therapy; MDD, major depressive disorder; RCT, randomized controlled trial.CC BY-NC · PubMed Central
Figure 2. Network for the (a) by-class analysis and (b) by-treatment analysis. Note: The size (area) of the nodes is proportional to the number of patients on treatment. The width of the lines is proportional to the number of patients in trials with direct comparison between the nodes. The numbers on the lines indicate the number of trials with direct comparisons, if it is more than one. Abbreviations: MOAI, monoamine-oxidase inhibitor; SNRI, serotonin and norepinephrine reuptake inhibitor; SSRI, selective serotonin reuptake inhibitor; TCA, tricyclic antidepressant.
Figure 2. Network for the (a) by-class analysis and (b) by-treatment analysis. Note: The size (area) of the nodes is proportional to the number of patients on treatment. The width of the lines is proportional to the number of patients in trials with direct comparison between the nodes. The numbers on the lines indicate the number of trials with direct comparisons, if it is more than one. Abbreviations: MOAI, monoamine-oxidase inhibitor; SNRI, serotonin and norepinephrine reuptake inhibitor; SSRI, selective serotonin reuptake inhibitor; TCA, tricyclic antidepressant.CC BY-NC · PubMed Central
Figure 3. Standardized mean differences in Digit Symbol Substitution Test (DSST) of antidepressants based on direct evidence from clinical studies included in the network of evidence. Abbreviations: SMD, standardized mean difference.
Figure 3. Standardized mean differences in Digit Symbol Substitution Test (DSST) of antidepressants based on direct evidence from clinical studies included in the network of evidence. Abbreviations: SMD, standardized mean difference.CC BY-NC · PubMed Central
Figure 4. Standardized mean difference vs placebo (a) by-class analysis and (b) by-treatment analysis. Abbreviations: CIT, citalopram; DES, desipramine; DUL, duloxetine; ESC, escitalopram; FLU, fluoxetine; MOAI, monoamine-oxidase inhibitor; NOR, nortriptyline; PHE, phenelzine; SER, sertraline; SNRI, serotonin and norepinephrine reuptake inhibitors; SSRI, selective serotonin reuptake inhibitors; TCA, tricyclic antidepressants; VOR, vortioxetine. *P<.05; ** P<.01.
Figure 4. Standardized mean difference vs placebo (a) by-class analysis and (b) by-treatment analysis. Abbreviations: CIT, citalopram; DES, desipramine; DUL, duloxetine; ESC, escitalopram; FLU, fluoxetine; MOAI, monoamine-oxidase inhibitor; NOR, nortriptyline; PHE, phenelzine; SER, sertraline; SNRI, serotonin and norepinephrine reuptake inhibitors; SSRI, selective serotonin reuptake inhibitors; TCA, tricyclic antidepressants; VOR, vortioxetine. *P<.05; ** P<.01.CC BY-NC · PubMed Central
Table 2. Treatment Effect Estimates (standardized mean differences of DSST change from baseline)
Table 2. Treatment Effect Estimates (standardized mean differences of DSST change from baseline)CC BY-NC · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Research works printed but not linked: 5

  1. European Medicines Agency, 2016, Brintellix summary of product characteristics
  2. Food and Drug Administration, 2016, Psychopharmacologic Drugs Advisory Committee: (PDAC) Meeting
  3. Haddjeri, 2012, Effects of the multimodal antidepressant Lu AA21004 on rat synaptic and cellular hippocampal plasticity and memory recognition, In: European Neuropsychopharmacology, 22, S303
  4. NICE, 2013, Specification for manufacturer/sponsor submission of evidence
  5. World Health Organization, 2016, Fact sheet N°369

Cited by

See all 144

Metadata

Authors
Baune, B. T., Brignone, M., & Larsen, K. G.
Affiliations
  • The University of Adelaide (AU)
  • Lundbeck SAS, Issy-les-Moulineaux, France
  • Lundbeck (Denmark) (DK)
Corresponding author
Brignone, Mélanie
Venue
International Journal of Neuropsychopharmacology
Published
2017-10-19
Volume
21
Issue
2
Pages
97-107
ISSN
  • 1461-1457 (ISSN-L)
  • 1469-5111
OpenAlex
W2765333294
Cited by
140
References
42
Citations by year
2026: 9 · 2025: 21 · 2024: 16 · 2023: 20 · 2022: 11 · 2021: 22 · 2020: 18 · 2019: 16 · 2018: 6 · 2017: 1
FWCI
7.83
Type
journal article
Language
en
Open access
Locations
  • The International Journal of Neuropsychopharmacology (publishedVersion, cc-by-nc)
  • PubMed Central (publishedVersion, cc-by-nc)
  • PubMed (publishedVersion)
  • Minerva Access (University of Melbourne) (submittedVersion, cc-by-nc)
  • Adelaide Research & Scholarship (AR&S) (University of Adelaide) (submittedVersion, cc-by-nc)
Funders
H. Lundbeck A/S and Takeda Pharmaceutical Company, Ltd
Topics
  • Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
  • Social Sciences › Psychology › Experimental and Cognitive Psychology › Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes
  • Life Sciences › Neuroscience › Biological Psychiatry › Tryptophan and brain disorders
Keywords
major depressive disorder, cognitive impairment, antidepressants, Digit Symbol Substitution Test, vortioxetine, selective serotonin reuptake inhibitors, serotonin-norepinephrine reuptake inhibitors, tricyclic antidepressants, escitalopram, nortriptyline
MeSH terms
Network Meta-Analysis, Antidepressive Agents, Depressive Disorder, Major, Major Depressive Disorder, Humans, Neuropsychological Tests, Cognitive Dysfunction

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.